Rivermark Medical Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $20M

  • Investors
  • 8

Rivermark Medical General Information

Description

Developer of a minimally invasive therapy device designed to restore urinary function in patients. The company specializes in invasive first-line device therapy developed by urologists that reliably reduces benign prostatic hyperplasia symptoms with minimal side effects with almost no patient downtime and no need for a post-procedural catheter, enabling patients an early return to normal daily life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 758 North Broadway
  • Suite 234
  • Milwaukee, WI 53202
  • United States
+1 (773)
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 758 North Broadway
  • Suite 234
  • Milwaukee, WI 53202
  • United States
+1 (773)

Rivermark Medical Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rivermark Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series D) 01-Apr-2026 $20M Completed Generating Revenue
3. Later Stage VC (Series C) 08-Oct-2024 Completed Clinical Trials - Phase 2
2. Early Stage VC (Series B) 28-Jul-2023 $2.15M $4.65M Completed Product Development
1. Early Stage VC (Series A) 15-Nov-2021 $2.5M $2.5M Completed Product Development
To view Rivermark Medical’s complete valuation and funding history, request access »

Rivermark Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
Series C
Series B 6,045,451 $0.000100 8% $0.68 $0.68 1x $0.68 7.83%
Series A 5,144,137 $0.000100 8% $0.5 $0.5 1x $0.5 6.66%
To view Rivermark Medical’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Rivermark Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a minimally invasive therapy device designed to restore urinary function in patients. The company specializ
Therapeutic Devices
Milwaukee, WI
8 As of 2024

Yokneam, Israel
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rivermark Medical Competitors (4)

One of Rivermark Medical’s 4 competitors is Butterfly Medical, a Venture Capital-Backed company based in Yokneam, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Butterfly Medical Venture Capital-Backed Yokneam, Israel
Zenflow Venture Capital-Backed South San Francisco, CA
ProVerum Venture Capital-Backed Dublin, Ireland
Urotronic Private Equity-Backed Plymouth, MN
To view Rivermark Medical’s complete competitors history, request access »

Rivermark Medical Patents

Rivermark Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023347315-A1 Intraluminal stent with handle for treating benign prostatic hyperplasia Pending 23-Sep-2022
EP-4590244-A1 Intraluminal stent with handle for treating benign prostatic hyperplasia Pending 23-Sep-2022
EP-4590244-A4 Intraluminal stent with handle for treating benign prostatic hyperplasia Pending 23-Sep-2022
US-12357479-B2 Intraluminal stent with handle for treating benign prostatic hyperplasia Active 23-Sep-2022
US-20240115405-A1 Intraluminal stent with handle for treating benign prostatic hyperplasia Active 23-Sep-2022 A61F2/9517
To view Rivermark Medical’s complete patent history, request access »

Rivermark Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rivermark Medical Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Andera Partners PE/Buyout Minority
American Century Investments Asset Manager Minority
Clarevia Ventures Venture Capital Minority
Golden Angels Investors Angel Group Minority
Time BioVentures Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Rivermark Medical FAQs

  • When was Rivermark Medical founded?

    Rivermark Medical was founded in 2021.

  • Where is Rivermark Medical headquartered?

    Rivermark Medical is headquartered in Milwaukee, WI.

  • What is the size of Rivermark Medical?

    Rivermark Medical has 8 total employees.

  • What industry is Rivermark Medical in?

    Rivermark Medical’s primary industry is Therapeutic Devices.

  • Is Rivermark Medical a private or public company?

    Rivermark Medical is a Private company.

  • What is the current valuation of Rivermark Medical?

    The current valuation of Rivermark Medical is .

  • What is Rivermark Medical’s current revenue?

    The current revenue for Rivermark Medical is .

  • How much funding has Rivermark Medical raised over time?

    Rivermark Medical has raised $54.7M.

  • Who are Rivermark Medical’s investors?

    Andera Partners, American Century Investments, Clarevia Ventures, Golden Angels Investors, and Time BioVentures are 5 of 8 investors who have invested in Rivermark Medical.

  • Who are Rivermark Medical’s competitors?

    Butterfly Medical, Zenflow, ProVerum, and Urotronic are competitors of Rivermark Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process